VHL and primary familial polycythemia due to EPO receptor mutation: Variation in VHL can cause familial erythrocytosis (ECYT2 [MIM: 263400]), von Hippel–Lindau syndrome (VHL [MIM: 193300]) and clear cell renal carcinoma (CCRC [MIM: 144700]) (Gossage et al., 2015).